(fifthQuint)Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets.

 Pediatric Asthma Clinical Effectiveness study (PEACE).

 A Randomized, Double-Blind, Double Dummy, Parallel Group comparative clinical study of Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID) via DISKUS with Oral montelukast (5mg QD) Chewable Tablets in Children 6-14 years of Age with Persistent Asthma.

 Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets@highlight

This study is being conducted to demonstrate the superior clinical effectiveness of Salmeterol/Fluticasone Propionate compared to montelukast in the management of persistent asthma in children aged 6-14 years, and to assess the effect of each treatment [Salmeterol/Fluticasone Propionate (50/100 mcg) and montelukast (5 mg)] on lung function, asthma control, Health Outcomes including the child's quality of life as measured by Paediatric Asthma Quality of Life Questionnaire (PAQLQ) and the caregiver's quality of life as measured by Paediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ) at selected centers where a valid translation is available.

